| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ABBVIE INC | 156 | 10,000 | 0.00% | ||
| 2 | ZAFGEN INC COM | 13,307 | 42,000 | 0.00% | ||
| 3 | QUORUM HEALTH CORP | 23,725 | 172,000 | 0.01% | ||
| 4 | RMR GROUP INC | 7,441 | 294,000 | 0.01% | ||
| 5 | CELLDEX THERAPEUTICS INC NEW | 105,800 | 375,000 | 0.02% | ||
| 6 | XENCOR INC COM | 20,000 | 526,000 | 0.02% | ||
| 7 | AFFIMED N V COM | 294,213 | 530,000 | 0.02% | ||
| 8 | GLOBAL MED REIT INC COM NEW | 73,400 | 655,000 | 0.03% | ||
| 9 | NOVAVAX INC COM | 571,000 | 719,000 | 0.03% | ||
| 10 | TETRAPHASE PHARMACEUTICALS INC COM | 192,322 | 775,000 | 0.03% | ||
| 11 | BELLICUM PHARMACEUTICALS INCORPORATED | 60,000 | 817,000 | 0.03% | ||
| 12 | AURIS MED HLDG AG | 774,504 | 829,000 | 0.04% | ||
| 13 | FLEX PHARMA INC COM | 162,124 | 856,000 | 0.04% | ||
| 14 | INTELLIA THERAPEUTICS INC | 71,842 | 942,000 | 0.04% | ||
| 15 | ALLIQUA BIOMEDICAL INC | 1,650,000 | 974,000 | 0.04% | ||
| 16 | JUNO THERAPEUTICS INC COM | 56,900 | 1,073,000 | 0.05% | ||
| 17 | THERAPEUTICSMD INC | 187,100 | 1,080,000 | 0.05% | ||
| 18 | COMMUNITY HEALTH SYS INC NEW | 203,935 | 1,140,000 | 0.05% | ||
| 19 | GENMARK DIAGNOSTICS INC. | 93,349 | 1,143,000 | 0.05% | ||
| 20 | SPARK THERAPEUTICS INCORPORATED | 24,300 | 1,213,000 | 0.05% | ||
| 21 | Esperion Therapeutics Inc | 102,800 | 1,287,000 | 0.05% | ||
| 22 | HEALTHCARE TR AMER INC | 46,000 | 1,339,000 | 0.06% | ||
| 23 | UNIQURE NV | 241,021 | 1,350,000 | 0.06% | ||
| 24 | HCP INC | 45,500 | 1,352,000 | 0.06% | ||
| 25 | DYNAVAX TECHNOLOGIES CORP | 345,050 | 1,363,000 | 0.06% | ||
| 26 | CIDARA THERAPEUTICS INC | 132,472 | 1,378,000 | 0.06% | ||
| 27 | ACCELERON PHARMA INC | 54,450 | 1,390,000 | 0.06% | ||
| 28 | CHIMERIX INC | 308,892 | 1,421,000 | 0.06% | ||
| 29 | WELLTOWER INC | 21,400 | 1,432,000 | 0.06% | ||
| 30 | DIPLOMAT PHARMACY INC COM | 130,223 | 1,641,000 | 0.07% | ||
| 31 | IMPAX LABORATORIES INC | 124,335 | 1,647,000 | 0.07% | ||
| 32 | ALLSCRIPTS HEALTHCARE SOLUTN | 173,600 | 1,772,000 | 0.08% | ||
| 33 | ACHILLION PHARMACEUTICALS IN | 443,851 | 1,833,000 | 0.08% | ||
| 34 | HALOZYME THERAPEUTICS INC | 200,000 | 1,976,000 | 0.08% | ||
| 35 | FORWARD PHARMA A/S | 136,547 | 2,050,000 | 0.09% | ||
| 36 | HEALTHCARE RLTY TR | 68,000 | 2,062,000 | 0.09% | ||
| 37 | AMICUS THERAPEUTICS INC COM | 418,730 | 2,081,000 | 0.09% | ||
| 38 | ADR - Nabriva Therapeutics AG- Usd | 350,000 | 2,083,000 | 0.09% | ||
| 39 | MCKESSON CORP | 15,000 | 2,107,000 | 0.09% | ||
| 40 | ADAMAS PHARMACEUTICALS INC | 125,504 | 2,121,000 | 0.09% | ||
| 41 | ACADIA COMPANY COM | 64,900 | 2,148,000 | 0.09% | ||
| 42 | ENDOLOGIX INC | 386,750 | 2,212,000 | 0.09% | ||
| 43 | ADAPTIMMUNE THERAPEUTICS PLC | 566,368 | 2,294,000 | 0.10% | ||
| 44 | DBV TECHNOLOGIES S A | 65,600 | 2,305,000 | 0.10% | ||
| 45 | ARCA BIOPHARMA INCORPORATED COM PAR .001 | 811,227 | 2,312,000 | 0.10% | ||
| 46 | TENET HEALTHCARE CORP | 164,500 | 2,441,000 | 0.10% | ||
| 47 | ACCELERATE DIAGNOSTICS INC | 120,000 | 2,490,000 | 0.11% | ||
| 48 | COHERUS BIOSCIENCES INC COM | 90,000 | 2,534,000 | 0.11% | ||
| 49 | HORIZON PHARMA PLC | 162,900 | 2,636,000 | 0.11% | ||
| 50 | GRIFOLS S A SP ADR REP B | 166,000 | 2,668,000 | 0.11% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001104659-17-008451, filed 2017.02.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
